首页 > 最新文献

Evidence-based Oncology最新文献

英文 中文
Multidisciplinary genetic assessment has similar psychological impact to usual care for women at high risk of familial breast cancer 多学科遗传评估对家族性乳腺癌高危妇女的心理影响与常规护理相似
Pub Date : 2002-09-01 DOI: 10.1054/EBON.2002.0028
M. Schwartz, B. Peshkin
{"title":"Multidisciplinary genetic assessment has similar psychological impact to usual care for women at high risk of familial breast cancer","authors":"M. Schwartz, B. Peshkin","doi":"10.1054/EBON.2002.0028","DOIUrl":"https://doi.org/10.1054/EBON.2002.0028","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"4 1","pages":"108-109"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82663105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temozolomide does not increase overall survival in recurrent malignant glioma 替莫唑胺不能提高复发性恶性胶质瘤患者的总生存率
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0030
Roger Stupp MD
{"title":"Temozolomide does not increase overall survival in recurrent malignant glioma","authors":"Roger Stupp MD","doi":"10.1054/ebon.2002.0030","DOIUrl":"https://doi.org/10.1054/ebon.2002.0030","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 133-134"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71804466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adding cisplatin to gemcitabine improved response and progression-free survival for people with locally advanced or metastatic pancreatic cancer 在吉西他滨中加入顺铂可改善局部晚期或转移性胰腺癌患者的反应和无进展生存期
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0029
Carlo Riccardo Rossi
{"title":"Adding cisplatin to gemcitabine improved response and progression-free survival for people with locally advanced or metastatic pancreatic cancer","authors":"Carlo Riccardo Rossi","doi":"10.1054/ebon.2002.0029","DOIUrl":"https://doi.org/10.1054/ebon.2002.0029","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 123-125"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0029","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71804468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidisciplinary genetic assessment has similar psychological impact to usual care for women at high risk of familial breast cancer 多学科遗传评估对家族性乳腺癌高危妇女的心理影响与常规护理相似
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0028
Marc D. Schwartz PhD, Beth N. Peshkin MS
{"title":"Multidisciplinary genetic assessment has similar psychological impact to usual care for women at high risk of familial breast cancer","authors":"Marc D. Schwartz PhD, Beth N. Peshkin MS","doi":"10.1054/ebon.2002.0028","DOIUrl":"https://doi.org/10.1054/ebon.2002.0028","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 108-109"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71717994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adding long-acting release octreotide pamoate to tamoxifen does not improve tumor response in advanced breast cancer 在他莫昔芬中加入长效缓释奥曲肽并不能改善晚期乳腺癌的肿瘤反应
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0027
H. Sommer MD PhD, W. Janni MD
{"title":"Adding long-acting release octreotide pamoate to tamoxifen does not improve tumor response in advanced breast cancer","authors":"H. Sommer MD PhD, W. Janni MD","doi":"10.1054/ebon.2002.0027","DOIUrl":"https://doi.org/10.1054/ebon.2002.0027","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 113-114"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71750189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
p53 mutations are associated with resistance to platinum-based chemotherapy in ovarian cancer P53突变与卵巢癌患者对铂类化疗的耐药性有关
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0037
Dionyssios Katsaros MD, PhD
{"title":"p53 mutations are associated with resistance to platinum-based chemotherapy in ovarian cancer","authors":"Dionyssios Katsaros MD, PhD","doi":"10.1054/ebon.2002.0037","DOIUrl":"https://doi.org/10.1054/ebon.2002.0037","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 141-142"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0037","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71806052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
p53 mutations are associated with resistance to platinum-based chemotherapy in ovarian cancer P53突变与卵巢癌患者对铂类化疗的耐药性有关
Pub Date : 2002-09-01 DOI: 10.1054/EBON.2002.0037
D. Katsaros
{"title":"p53 mutations are associated with resistance to platinum-based chemotherapy in ovarian cancer","authors":"D. Katsaros","doi":"10.1054/EBON.2002.0037","DOIUrl":"https://doi.org/10.1054/EBON.2002.0037","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"69 1","pages":"141-142"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73443714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Liposome-encapsulated doxorubicin is less cardiotoxic than conventional doxorubicin for metastatic breast cancer 脂质体封装的阿霉素对转移性乳腺癌的心脏毒性比传统的阿霉素小
Pub Date : 2002-09-01 DOI: 10.1054/EBON.2002.0022
C. Shapiro
{"title":"Liposome-encapsulated doxorubicin is less cardiotoxic than conventional doxorubicin for metastatic breast cancer","authors":"C. Shapiro","doi":"10.1054/EBON.2002.0022","DOIUrl":"https://doi.org/10.1054/EBON.2002.0022","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"15 1","pages":"110-112"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84980241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound scan has 83% accuracy for assessing axillary nodal status in people with breast cancer 超声扫描评估乳腺癌患者腋窝淋巴结状态的准确率为83%
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0035
Franco Lumachi (Dr)
{"title":"Ultrasound scan has 83% accuracy for assessing axillary nodal status in people with breast cancer","authors":"Franco Lumachi (Dr)","doi":"10.1054/ebon.2002.0035","DOIUrl":"https://doi.org/10.1054/ebon.2002.0035","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 102-103"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71806732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alternating and sequential administration of docetaxel with fluorouracil, epirubicin and cyclophosphamide have similar safety profiles for metastatic breast cancer 多西紫杉醇与氟尿嘧啶、表柔比星和环磷酰胺交替序贯给药治疗转移性乳腺癌具有相似的安全性
Pub Date : 2002-09-01 DOI: 10.1054/EBON.2002.0036
J. Jassem
{"title":"Alternating and sequential administration of docetaxel with fluorouracil, epirubicin and cyclophosphamide have similar safety profiles for metastatic breast cancer","authors":"J. Jassem","doi":"10.1054/EBON.2002.0036","DOIUrl":"https://doi.org/10.1054/EBON.2002.0036","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"168 1","pages":"117-119"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74320967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Evidence-based Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1